Rituximab has already been successfully used to treat immune‐mediated bleeding disorders such as acquired factor VIII inhibitor. We report here a case of severe acquired factor V (FV) inhibitor deficiency due to FV inhibitor which has been dramatically improved after rituximab. Am. J. Hematol., 2008.
No takes yet. Share an insight, caveat, or question.
Lebrun et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: